TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
L’Occitane Group has sold British skincare brand Elemis to private equity firm PAI Partners, ending seven years of ownership. The price and other financial terms were not disclosed. PAI says it plans to focus on US growth, digital sales and selected premium retail channels.
L’Occitane Group has sold Elemis, the British skincare brand, to private equity firm PAI Partners after seven years of ownership. The companies have not disclosed the sale price or detailed terms; PAI says it will work with Elemis’s management on growth, including in the US and digital channels.
PAI described the deal as the next phase of Elemis’s development and said it intends to support the brand’s continued growth in the UK while accelerating its US expansion. Its stated priorities also include broadening Elemis’s reach through digital and selected premium retail channels. These are plans expressed by the buyer, not reported outcomes of the transaction.
Elemis will continue investing in its core product range and product innovation, according to the report, building on the Pro-Collagen franchise. PAI partners Gaëlle d’Engremont and Colm O’Sullivan cited the brand’s premium positioning, product performance and digital engagement as strengths. Their description of the market and brand performance reflects the buyers’ assessment.
L’Occitane said Elemis had nearly doubled net sales during its ownership to more than US$300 million in FY2026. The report also says the US now accounts for approximately half of Elemis net sales, after several years of double-digit annual growth, and that online channels generate an estimated half of sales. Those figures are attributed to the source report; it does not provide an underlying financial filing or define the periods and measurement basis for each estimate.
Elemis’s Next Ownership Chapter
The sale changes the ownership of a sizeable premium skincare business and gives PAI a platform with an established UK identity, international customers and substantial online sales, according to the reported figures. For L’Occitane, it marks a portfolio decision involving a brand that the group described as its first major acquisition.
The buyer’s stated focus suggests where the business may concentrate investment: expanding in the US, developing digital sales and adding selected premium retail distribution. Whether those priorities lead to changes in products, distribution or staffing has not been announced. For customers and retail partners, the immediate question is whether the new ownership will alter the brand’s operations or its product offering.
Products Worth Considering
LEVOIT Vital Pet Pro Smart Air Purifier
Garmin Venu 3S GPS Smartwatch with AMOLED Display, Soft Gold and French Gray Silicone Band
Fitbit Charge 6 Fitness Tracker – Obsidian/Black
As an affiliate, we earn on qualifying purchases.
Seven Years Under L’Occitane
Elemis was founded in London in 1989 by entrepreneur and investor Linda Steiner with co-founders Noella Gabriel, Sean Harrington and Oriele Frank. L’Occitane’s chairman and chief executive, Reinold Geiger, called it the group’s first major acquisition and said the brand helped mark its development as a multi-brand company.
The source report says Elemis’s US business now represents about half of net sales, following investment in the market since 2015. It also estimates online sales at roughly half of the total, through the brand’s direct-to-consumer platform and digital retail partners. The figures help explain why both US expansion and digital growth feature in PAI’s stated plans, though they do not establish how the new owner will allocate investment.
““We see significant opportunities to accelerate growth in the US and expand the brand’s digital business, while preserving its distinctive British identity.””
— Gaëlle d’Engremont and Colm O’Sullivan, PAI Partners
Sale Terms and Operating Plans
The purchase price and financial terms have not been disclosed. The report also does not specify when the transaction will close, whether regulatory or other conditions apply, or whether PAI will change Elemis’s leadership, workforce, manufacturing or retail arrangements. No detailed investment timetable or quantified growth targets were provided.
The reported revenue and channel figures are not accompanied by a detailed breakdown, and the source does not clarify the basis for the sales estimates. PAI’s statements about future expansion are plans rather than evidence that growth has already occurred.
How PAI Plans to Grow Elemis
PAI says it will work with the Elemis management team on growth in the UK and the US, while developing digital business and selected premium retail distribution. The brand is also expected to continue investing in its core range and product innovation, including the Pro-Collagen franchise, according to the report.
The next concrete indicators will be any announcement about completion and transaction terms, followed by updates from PAI or Elemis on investment, distribution or product plans. No dates for those announcements were given.
Key Questions
Who bought Elemis?
PAI Partners, a private equity firm, bought the British skincare brand from L’Occitane Group.
How much did PAI Partners pay?
The sale price was not disclosed in the source report. Other financial terms were not provided.
What does PAI plan to do with Elemis?
PAI says it will work with Elemis’s management to support growth, with a focus on the US, digital sales and selected premium retail channels. These are stated plans; no timetable or quantified targets were announced.
How large is Elemis’s business?
The source report says net sales reached more than US$300 million in FY2026, nearly double during L’Occitane’s ownership. It estimates that the US and online channels each account for about half of sales, but does not provide detailed supporting figures.
Will Elemis products or leadership change?
No product, leadership or operational changes were announced in the report. Elemis is expected to continue investing in its core range and innovation, but further details about operations under PAI remain unclear.
Source: cosmeticsbusiness.com
